• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板与淋巴细胞比值是急性冠脉综合征患者长期死亡率的一个预测指标。

Platelet-to-lymphocyte ratio is a predictor of long-term mortality in patients with acute coronary syndrome.

作者信息

Oylumlu Mustafa, Oylumlu Muhammed, Arslan Bayram, Polat Nihat, Özbek Mehmet, Demir Muhammed, Yildiz Abdulkadir, Toprak Nizamettin

机构信息

Department of Cardiology, School of Medicine, Dicle University, Diyarbakır, Turkey.

Department of Cardiology, Kastamonu Anatolian Hospital, Kastamonu, Turkey.

出版信息

Postepy Kardiol Interwencyjnej. 2020 Jun;16(2):170-176. doi: 10.5114/aic.2020.95859. Epub 2020 Jun 23.

DOI:10.5114/aic.2020.95859
PMID:32636901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7333190/
Abstract

INTRODUCTION

Atherosclerosis is a chronic inflammatory process and inflammation is an important component of acute coronary syndrome (ACS). Platelet-to-lymphocyte ratio (PLR) is a useful parameter showing the degree of the inflammatory response.

AIM

To explore the association between PLR and long-term mortality in patients with ACS.

MATERIAL AND METHODS

A total of 538 patients who had a diagnosis of ACS between January 2012 and August 2013 were followed up to 60 months. On admission, blood sampling to calculate PLR and detailed clinical data were obtained.

RESULTS

In total, 538 patients with a mean age of 61.5 ±13.1 years (69% male) were enrolled in the study. Median follow-up was 79 months (IQR: 74-83 months). Patients were divided into 3 tertiles based on PLR levels. Five-year mortality of the patients was significantly higher among patients in the upper PLR tertile when compared with the lower and middle PLR tertile groups (55 (30.7%) vs. 27 (15.0%) and 34 (19.0%); < 0.001, = 0.010 respectively). In the Cox regression analysis, a high level of PLR was an independent predictor of 5-year mortality (OR = 1.005, 95% CI: 1.001-1.008, = 0.004). Kaplan-Meier analysis according to the long-term mortality-free survival revealed the higher occurrence of mortality in the third PLR tertile group compared to the first ( < 0.001) and second tertiles ( = 0.009).

CONCLUSIONS

PLR, which is an easily calculated and universally available marker, may be useful in long-term risk classification of patients presenting with ACS.

摘要

引言

动脉粥样硬化是一种慢性炎症过程,炎症是急性冠状动脉综合征(ACS)的重要组成部分。血小板与淋巴细胞比值(PLR)是反映炎症反应程度的一个有用参数。

目的

探讨PLR与ACS患者长期死亡率之间的关联。

材料与方法

对2012年1月至2013年8月期间诊断为ACS的538例患者进行了60个月的随访。入院时,采集血样以计算PLR并获取详细的临床数据。

结果

本研究共纳入538例患者,平均年龄61.5±13.1岁(男性占69%)。中位随访时间为79个月(四分位间距:74 - 83个月)。根据PLR水平将患者分为三个三分位数组。与低PLR三分位数组和中PLR三分位数组相比,高PLR三分位数组患者的五年死亡率显著更高(55例(30.7%) vs. 27例(15.0%)和34例(19.0%);P<0.001,P = 0.010)。在Cox回归分析中,高水平的PLR是5年死亡率的独立预测因素(OR = 1.005,95%置信区间:1.001 - 1.008,P = 0.004)。根据长期无死亡生存情况进行的Kaplan-Meier分析显示,与第一三分位数组(P<0.001)和第二三分位数组(P = 0.009)相比,第三PLR三分位数组的死亡率更高。

结论

PLR是一种易于计算且普遍可用的标志物,可能有助于对ACS患者进行长期风险分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f6/7333190/c9681cac46fe/PWKI-16-40799-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f6/7333190/5692219660eb/PWKI-16-40799-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f6/7333190/c9681cac46fe/PWKI-16-40799-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f6/7333190/5692219660eb/PWKI-16-40799-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f6/7333190/c9681cac46fe/PWKI-16-40799-g002.jpg

相似文献

1
Platelet-to-lymphocyte ratio is a predictor of long-term mortality in patients with acute coronary syndrome.血小板与淋巴细胞比值是急性冠脉综合征患者长期死亡率的一个预测指标。
Postepy Kardiol Interwencyjnej. 2020 Jun;16(2):170-176. doi: 10.5114/aic.2020.95859. Epub 2020 Jun 23.
2
Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome.血小板与淋巴细胞比值是急性冠状动脉综合征患者院内死亡率的一个预测指标。
Anatol J Cardiol. 2015 Apr;15(4):277-83. doi: 10.5152/akd.2014.5366. Epub 2014 Apr 8.
3
Usefulness of Platelet-to-Lymphocyte Ratio to Predict Long-Term All-Cause Mortality in Patients at High Risk of Coronary Artery Disease Who Underwent Coronary Angiography.血小板与淋巴细胞比值对接受冠状动脉造影的高危冠心病患者长期全因死亡率的预测价值
Am J Cardiol. 2018 May 1;121(9):1021-1026. doi: 10.1016/j.amjcard.2018.01.018. Epub 2018 Feb 7.
4
Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study.血小板与淋巴细胞比值可作为急性肺栓塞患者住院期和远期不良结局的新型标志物:一项单中心大样本研究。
Thromb Res. 2017 Feb;150:33-40. doi: 10.1016/j.thromres.2016.12.006. Epub 2016 Dec 10.
5
Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction.血小板/淋巴细胞比值对非 ST 段抬高型心肌梗死患者全因死亡率的预测价值。
J Thromb Thrombolysis. 2012 Oct;34(3):326-34. doi: 10.1007/s11239-012-0718-6.
6
Platelet to Lymphocyte Ratio on Admission and Prognosis in Patients with Acute Cardiogenic Pulmonary Edema.急性心源性肺水肿患者入院时的血小板与淋巴细胞比值及预后
J Emerg Med. 2018 Oct;55(4):465-471. doi: 10.1016/j.jemermed.2018.06.021. Epub 2018 Aug 14.
7
The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation.血小板与淋巴细胞比值作为接受择期经皮冠状动脉介入治疗及支架植入术的冠心病患者全因死亡率的预测指标。
J Saudi Heart Assoc. 2015 Jul;27(3):144-51. doi: 10.1016/j.jsha.2015.02.004. Epub 2015 Feb 17.
8
The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndrome.血小板与淋巴细胞比值对急性冠状动脉综合征长期预后的年龄特异性预后影响。
Eur Heart J Open. 2021 Oct 27;2(1):oeab031. doi: 10.1093/ehjopen/oeab031. eCollection 2022 Jan.
9
Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.血小板/淋巴细胞比值与接受直接冠状动脉介入治疗的ST段抬高型急性心肌梗死患者的心肌灌注受损以及院内和长期不良结局相关。
Postepy Kardiol Interwencyjnej. 2015;11(4):288-97. doi: 10.5114/pwki.2015.55599. Epub 2015 Jan 12.
10
Correlation of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) with Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Interventions.急性冠脉综合征患者接受经皮冠状动脉介入治疗时中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)与对比剂肾病的相关性
Cureus. 2020 Dec 3;12(12):e11879. doi: 10.7759/cureus.11879.

引用本文的文献

1
Machine Learning-Driven Prediction of One-Year Readmission in HFrEF Patients: The Key Role of Inflammation.机器学习驱动的射血分数降低的心力衰竭(HFrEF)患者一年再入院预测:炎症的关键作用
Clin Interv Aging. 2025 Jul 24;20:1071-1084. doi: 10.2147/CIA.S528442. eCollection 2025.
2
Platelet-To-Lymphocyte Ratio Efficiency in Predicting Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Meta-Analysis.血小板与淋巴细胞比值预测急性冠状动脉综合征经皮冠状动脉介入治疗后主要不良心血管事件的效能:一项荟萃分析
Rev Cardiovasc Med. 2025 May 21;26(5):27942. doi: 10.31083/RCM27942. eCollection 2025 May.
3

本文引用的文献

1
Relationship between platelet-to-lymphocyte ratio and the presence and severity of coronary artery ectasia.血小板与淋巴细胞比值与冠状动脉扩张的存在及严重程度之间的关系。
Anatol J Cardiol. 2016 Nov;16(11):857-862. doi: 10.14744/AnatolJCardiol.2015.6639. Epub 2016 Apr 21.
2
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.《2016年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
3
Global and regional patterns in cardiovascular mortality from 1990 to 2013.
Predictive Value of Peri-Coronary Fat Attenuation Index in Elderly Non-ST-Elevation Myocardial Infarction and Its Correlation with Platelet to Lymphocyte Ratio.
冠状动脉周围脂肪衰减指数在老年非ST段抬高型心肌梗死中的预测价值及其与血小板淋巴细胞比值的相关性
BMC Cardiovasc Disord. 2025 Apr 18;25(1):298. doi: 10.1186/s12872-025-04730-8.
4
Pan-Immune-Inflammatory Value is Superior to Other Inflammatory Indicators in Predicting Inpatient Major Adverse Cardiovascular Events and Severe Coronary Artery Stenosis after Percutaneous Coronary Intervention in STEMI Patients.全免疫炎症值在预测ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后的住院主要不良心血管事件和严重冠状动脉狭窄方面优于其他炎症指标。
Rev Cardiovasc Med. 2024 Aug 20;25(8):294. doi: 10.31083/j.rcm2508294. eCollection 2024 Aug.
5
Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL-Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients.评估炎症性血液学比值(NLR、PLR、MLR、LMR 和单核细胞/高密度脂蛋白胆固醇比值)在急性心肌梗死中的作用及在年轻患者中的特点。
Int J Mol Sci. 2023 Sep 21;24(18):14378. doi: 10.3390/ijms241814378.
6
Association of inflammatory markers with all-cause mortality and cardiovascular mortality in postmenopausal women with osteoporosis or osteopenia.绝经后骨质疏松症或骨量减少症妇女的炎症标志物与全因死亡率和心血管死亡率的关系。
BMC Womens Health. 2023 Sep 14;23(1):487. doi: 10.1186/s12905-023-02631-6.
7
The prognostic value of admission lymphocyte-to-monocyte ratio in critically ill patients with acute myocardial infarction.入院时淋巴细胞与单核细胞比值对急性心肌梗死危重症患者的预后价值。
BMC Cardiovasc Disord. 2022 Jul 7;22(1):308. doi: 10.1186/s12872-022-02745-z.
8
Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans.下肢动脉硬化闭塞症后主要心血管和脑血管不良事件的长期风险新见解。
Front Cardiovasc Med. 2022 Apr 4;9:853583. doi: 10.3389/fcvm.2022.853583. eCollection 2022.
9
The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality.严重急性呼吸综合征冠状病毒2感染、炎症与高凝状态之间的联系——血液流变学改变对心血管死亡率的影响
J Clin Med. 2021 Jul 6;10(14):3015. doi: 10.3390/jcm10143015.
1990 年至 2013 年全球和各区域心血管疾病死亡率模式。
Circulation. 2015 Oct 27;132(17):1667-78. doi: 10.1161/CIRCULATIONAHA.114.008720.
4
Platelet to Lymphocyte Ratio as a Prognostic Marker of In-Hospital and Long-Term Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction.血小板与淋巴细胞比值作为ST段抬高型心肌梗死患者院内及长期主要不良心血管事件的预后标志物
Angiology. 2016 Apr;67(4):336-45. doi: 10.1177/0003319715591751. Epub 2015 Jun 22.
5
The association between platelet/lymphocyte ratio and coronary artery disease severity.血小板/淋巴细胞比值与冠状动脉疾病严重程度之间的关联。
Anatol J Cardiol. 2015 Aug;15(8):640-7. doi: 10.5152/akd.2014.5565. Epub 2014 Jul 11.
6
Relationship between platelet-to-lymphocyte ratio and coronary slow flow.血小板与淋巴细胞比值与冠状动脉慢血流的关系。
Anatol J Cardiol. 2015 May;15(5):391-5. doi: 10.5152/akd.2014.5376. Epub 2014 Apr 8.
7
Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome.血小板与淋巴细胞比值是急性冠状动脉综合征患者院内死亡率的一个预测指标。
Anatol J Cardiol. 2015 Apr;15(4):277-83. doi: 10.5152/akd.2014.5366. Epub 2014 Apr 8.
8
Platelet to lymphocyte ratio: a simple and valuable prognostic marker for acute coronary syndrome.血小板与淋巴细胞比值:急性冠状动脉综合征的一种简单且有价值的预后标志物。
Int J Cardiol. 2014 Dec 15;177(2):597-8. doi: 10.1016/j.ijcard.2014.08.143. Epub 2014 Aug 28.
9
Cardiovascular disease in Europe 2014: epidemiological update.欧洲 2014 年心血管疾病:流行病学更新。
Eur Heart J. 2014 Nov 7;35(42):2950-9. doi: 10.1093/eurheartj/ehu299. Epub 2014 Aug 19.
10
The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention.血小板与淋巴细胞比值与接受直接冠状动脉介入治疗的ST段抬高型心肌梗死临床结局之间的关系。
Blood Coagul Fibrinolysis. 2014 Dec;25(8):806-11. doi: 10.1097/MBC.0000000000000150.